tokens: Objective responses also occurred in studies that explored sequential use of exemestane after failure of aminoglutethimide ( 26 % with exemestane 200 mg / day ) or other nonsteroidal aromatase inhibitors ( 6.6 % with exemestane 25 mg / day ) .
folded_tokens: objective response also occur in study that explore sequential use of exemestane after failure of aminoglutethimide ( 26 % with exemestane 200 mg / day ) or other nonsteroidal aromatase inhibitor ( 6.6 % with exemestane 25 mg / day ) .